|
AU5400000A
|
|
Pharmaceutical preparation containing modifications of surfactant protein b (sp-b) and surfactant protein c (sp-c)
|
|
AU5074400A
|
|
Surfactant protein c esters
|
|
AU4562693A
|
|
Contrast agents for mr diagnosis
|
|
AU8445791A
|
|
Use of pyridylmethylsulphinyl-1h-benzimidazole derivates in the treatment of illnesses caused by helicobacter bacteria
|
|
AU7652391A
|
|
Novel pyridine esters
|
|
AU7078691A
|
|
Use of urapidile and derivatives for treating arteriosclerotic diseases
|
|
AU5312086A
|
|
New piperazine derivatives
|
|
AU8683682A
|
|
Phenylalkyloxiranecarboxylic acids, a process for their preparation, their use, and medicaments containing them
|
|
AU7645981A
|
|
Inhalation device
|
|
AU6335780A
|
|
Substituted quinoline-alkanecarboxylic acids, their preparation and use, and medicaments containing them
|
